Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

Dry AMD is more common, accounting for about 80–90% of cases. It occurs when the macula, the part of the retina responsible for central vision, gradually thins with age, leading to the accumulation of ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Brain-computer interface (BCI) developer Science Corporation today announced preliminary clinical trial results for its Prima ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

SOL-1 is now expected to be enrolled and fully randomized by year-end 2024Topline clinical data from SOL-1 are now expected in Q4 2025BEDFORD, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

Designed to treat age-related macular degeneration, the coin-sized chip is designed to create optical coherence tomography ...

An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...